Saadatmand Massumeh, Al-Awsi Ghaidaa Raheem Lateef, Alanazi Abdullah D, Sepahvand Asghar, Shakibaie Mojtaba, Shojaee Saeedeh, Mohammadi Rasool, Mahmoudvand Hossein
Student Research Committee, Lorestan University of Medical Sciences, Khorramabad, Iran.
Department of Radiological Techniques, Al-Mustaqbal University College, Babylon, Iraq.
Saudi J Biol Sci. 2021 Nov;28(11):6454-6460. doi: 10.1016/j.sjbs.2021.07.007. Epub 2021 Jul 10.
Today, a suitable vaccine has not yet been discovered to prevent infection. Therefore, prophylaxis can be suggested as the preferred approach to prevent toxoplasmosis. This study aims to evaluate the prophylactic effects of synthesized zinc nanoparticles (ZnNPs) using Vera., by microwave method on chronic toxoplasmosis in mice.
BALB/c Mice orally administrated with ZnNPs the doses of 32.5, 75, 150 mg/kg/day for two weeks. On the 15th day, the mice were intraperitoneally infected with the Tehran strain of (25 tissue cysts). The mean diameter and the numbers of brain tissue cysts, as well as the mRNA levels of inducible nitric oxide synthesize (iNOs), and interferon-gamma (IFN-γ) in mice of each experimental group were evaluated.
The synthesized ZnNPs represent a spherical form with a size ranging from 30 to 80 nm. The results revealed that oral administration of Zn NPs at the doses of 32.5 (p < 0.001) and 75 mg/kg/day (p < 0.001) for 14 days significantly reduced the mean number and diameter of the brain tissue cysts in tested mice. No tissue cyst was observed after oral administration of Zn NPs at the doses of 150 mg/kg. Based on the results of Real-time PCR analysis, the expression level of IFN-γ and iNOs was significantly increased (p < 0.001) in mice treated with 32.5, 75, 150 mg/kg/day for two weeks.
The obtained findings of the current investigation exhibit the significant prophylactic effects of ZnNPs against chronic toxoplasmosis in mice; so that oral administration of ZnNPs the doses 32.5, 75, 150 mg/kg reduced the parasite load and even completely controlled the infection in mice. The results show that the ZnNPs had strengthened the innate immune system which could be the reason for its strong prophylactic effects. However, further and clinical investigations are required to confirm these results as well as other possible mechanisms that can trigger these pharmacological properties.
如今,尚未发现合适的疫苗来预防感染。因此,可建议将预防作为预防弓形虫病的首选方法。本研究旨在评估使用微波法合成的维拉锌纳米颗粒(ZnNPs)对小鼠慢性弓形虫病的预防效果。
将BALB/c小鼠以32.5、75、150毫克/千克/天的剂量口服ZnNPs,持续两周。在第15天,将小鼠腹腔注射德黑兰株(25个组织包囊)进行感染。评估每个实验组小鼠脑组织包囊的平均直径和数量,以及诱导型一氧化氮合酶(iNOs)和干扰素-γ(IFN-γ)的mRNA水平。
合成的ZnNPs呈球形,尺寸范围为30至80纳米。结果显示,以32.5(p < 0.001)和75毫克/千克/天(p < 0.001)的剂量口服Zn NPs 14天,可显著降低受试小鼠脑组织包囊的平均数量和直径。以150毫克/千克的剂量口服Zn NPs后未观察到组织包囊。基于实时PCR分析结果,在以32.5、75、150毫克/千克/天的剂量处理两周的小鼠中,IFN-γ和iNOs的表达水平显著升高(p < 0.001)。
本研究获得的结果显示ZnNPs对小鼠慢性弓形虫病具有显著的预防效果;口服32.5、75、150毫克/千克剂量的ZnNPs可降低寄生虫负荷,甚至完全控制小鼠感染。结果表明,ZnNPs增强了先天免疫系统,这可能是其强大预防效果的原因。然而,需要进一步的研究和临床研究来证实这些结果以及其他可能引发这些药理特性的机制。